<DOC>
	<DOCNO>NCT02076269</DOCNO>
	<brief_summary>This purpose study obtain inhalation profile subject severe Chronic Obstructive Pulmonary Disease ( COPD ) . This study investigational medicinal product . Each subject attend clinic 2 occasion , initially screen visit assessment include ( Visit 1 ) . The maximum time subject may enrol study 33 day screen visit follow .</brief_summary>
	<brief_title>Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Males/females age 40 year , time signing informed consent . A female patient eligible participate : Non childbearing potential , female postmenopausal , define 12 month spontaneous amenorrhea [ questionable case , blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 milli international unit ( MIU ) /milliliter ( mL ) estradiol &lt; 40 picograms ( pg ) /mL ( &lt; 147 picomoles [ pmol ] /Liter [ L ] ) confirmatory ] OR Perimenopausal premenopausal , negative pregnancy test determine serum urine human chorionic gonadotropin ( hCG ) test , confirm screen Visit 1 , compute tomography ( CT ) scan conduct . Capable give write informed consent , include compliance requirement restriction list consent form Available complete study . Clinically diagnose COPD , least 6 month prior screen : severe COPD define current GOLD guideline . The following lung function criterion post bronchodilator : Very severe COPD . Forced expiratory volume 1 second ( FEV1 ) /forced vital capacity ( FVC ) &lt; 70 % , AND FEV1 &lt; 30 % predict screening . Patient smoker ex smoker smoke history least 10 pack year ( Pack year = ( cigarette per day smoked/20 ) x number year smoke ) ) . No history acute respiratory disease within two week prior inclusion ( patient back usual stable baseline lung function ) No history inflammatory lung condition . Patients previous lung cancer include long fully treat free disease precede 5 year . No exacerbation disease require hospitalisation within previous two week prior inclusion ( patient back usual stable baseline lung function ) Able withhold short act bronchodilator 6 hour long act bronchodilator 12 hour start study assessment . A patient asthma COPD . A patient past present disease , judge Investigator , may affect patient safety influence outcome study . History alcohol abuse . The patient respiratory tract infection within two week start study ( patient back usual stable baseline lung function ) The patient history claustrophobia . As result medical interview , physical examination screen investigation , physician responsible considers patient unfit study . The patient unable perform Inhalation Profile assessment correctly . The patient receive investigational drug device participate research trial within 30 day start study . The patient radiological investigation significant radiation burden ( significant radiation burden define International Commission Radiological Protection ( ICRP ) category IIb : 50 millisievert ( mSv ) normalise bodyweight addition natural background radiation , previous 2 year include dose study ) . The patient oxygen ( O2 ) dependant time day study assessment complete . Unwillingness inability follow procedure outline protocol . Patient keep regulatory judicial order institution . Patient mentally legally incapacitate</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HRCT</keyword>
	<keyword>Dry Powder Inhaler</keyword>
	<keyword>COPD</keyword>
	<keyword>Pharyngometry</keyword>
	<keyword>Inhalation Profiles</keyword>
</DOC>